BioSpace News Archive

Quest Diagnostics Incorporated announced today preliminary financial results for the fourth quarter and full year 2021.

DALI Medical Devices today announced the first commercial implementation of its SAN-Light passive safety needle.

Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B74710126) describing the safety and immunogenicity of PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in 570 adults in the United States 65 years of age or older when administered at the same time as the Pfizer-BioNTech COVID-19 Vaccine or when each vaccine was given with placebo.

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as “Cipla” today announced that it will participate at the 40th Annual J.P. Morgan Healthcare Conference,

Aro Biotherapeutics today announced the appointment of Sukumar Sakamuri, Ph.D. as Chief Technology Officer and a member of the company’s executive leadership team.

The American Medical Association has issued two new Current Procedural Terminology codes for 98980 and 98981 Remote therapeutic monitoring/treatment management services.

IMV Inc. today announced a first patient dosed in the VITALIZE Phase 2B clinical trial. VITALIZE will further evaluate the clinical benefit of IMV’s lead compound, maveropepimut-S (MVP-S).

Paragon 28, Inc. today announced the acquisition of Disior Oy.

KemPharm, Inc. today announced that the Company will host a conference call and live audio webcast on Wednesday, January 19, 2022, at 4:30 p.m. ET, to discuss the Company’s strategy for advancing and expanding its development pipeline.

Codagenix, Inc. today announced the appointment of Bruce E. Taillon, Ph.D., as Executive Vice President of Animal Health.